How many DM Medical Oncology thesis topics are available?

60+ DM Medical Oncology thesis topics are listed on this page, covering the major subsections of the curriculum. Click any title to get its objective on WhatsApp.

Do these Medical Oncology topics include the objectives?

Yes. Every title has a worked-out objective, synopsis structure, sample-size calculation and statistical plan. Click "Get Objective" on any title to receive it on WhatsApp.

Is this useful for DM, DNB and FCPS Medical Oncology candidates?

Yes. These thesis topics are aligned with NMC, NBE and DNB Medical Oncology curricula and suit DM, DNB Medical Oncology and FCPS candidates alike.

Can you help with synopsis, protocol and data analysis too?

Yes. Beyond topic selection, our team provides synopsis writing, IEC/IRB-ready protocol drafting, data collection forms, statistical analysis (SPSS/R), thesis writing and journal publication support.

DM Medical Oncology Thesis Topics 2026 (60+ Titles)

001

Clinico-pathological profile, receptor status and treatment outcome of breast cancer in young women (below 40 years)

Breast & Gynaecological Cancer Prospective observational study Prospective Study

Objective

DM Medical Oncology — Thesis Title List

Clinico-pathological profile, receptor status and treatment outcome of breast cancer in young women (below 40 years)

Pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer and its correlation with molecular subtype

Cardiotoxicity of trastuzumab and anthracycline-based chemotherapy in HER2-positive breast cancer: incidence and risk factors

Outcome of platinum-based chemotherapy in epithelial ovarian cancer and predictors of platinum resistance

Concurrent chemoradiation in locally advanced carcinoma cervix: toxicity profile and treatment response

Efficacy and toxicity of CDK4/6 inhibitors with endocrine therapy in hormone receptor-positive metastatic breast cancer: a real-world study

Clinico-pathological profile and EGFR/ALK mutation status in non-small cell lung cancer and response to targeted therapy

Clinical profile and outcome of lung cancer in never-smokers compared with smokers

Response and survival with immune checkpoint inhibitors in advanced non-small cell lung cancer: a single-centre experience

Clinical profile, treatment and survival in small cell lung cancer at a tertiary care centre

Quality of life and symptom burden in patients with advanced lung cancer on systemic therapy

Clinico-pathological profile and treatment outcome of colorectal cancer in young adults

Efficacy and toxicity of FOLFOX versus CAPOX as adjuvant chemotherapy in stage III colon cancer

Outcome of perioperative chemotherapy in locally advanced gastric cancer and predictors of response

Clinical profile and outcome of gall bladder cancer treated with gemcitabine-based chemotherapy

Sorafenib versus lenvatinib in advanced hepatocellular carcinoma: response and tolerability

Clinical profile and survival of pancreatic adenocarcinoma treated with FOLFIRINOX or gemcitabine-nab-paclitaxel

Clinical, cytogenetic and molecular profile of acute myeloid leukaemia and outcome of induction chemotherapy

Outcome of adults with acute lymphoblastic leukaemia treated with a paediatric-inspired protocol

Molecular response and survival in chronic myeloid leukaemia on imatinib and predictors of treatment failure

Clinical profile, staging and treatment outcome of diffuse large B-cell lymphoma treated with R-CHOP

Clinical profile and response to bortezomib-based therapy in multiple myeloma at a tertiary care centre

Clinical profile and outcome of Hodgkin lymphoma treated with ABVD and role of interim PET-CT

Febrile neutropenia in patients receiving chemotherapy: microbiological profile, MASCC score and outcome

Immune-related adverse events with checkpoint inhibitors across solid tumours: incidence, management and outcome

PD-L1 expression and its correlation with response to immunotherapy in non-small cell lung cancer and urothelial carcinoma

Efficacy and toxicity of tyrosine kinase inhibitors in metastatic renal cell carcinoma: a real-world analysis

Biosimilar versus innovator trastuzumab in HER2-positive breast cancer: response and safety

Clinical utility of next-generation sequencing in advanced solid tumours: actionable mutations and treatment impact

Symptom burden, quality of life and palliative care needs in patients with advanced cancer using ESAS and EORTC QLQ-C30

Prevalence and management of cancer pain and adequacy of analgesia using the WHO ladder in a tertiary oncology centre

Chemotherapy-induced nausea and vomiting: adherence to antiemetic guidelines and control rates

Prevalence of malnutrition in cancer patients using PG-SGA and its impact on chemotherapy tolerance

Depression, anxiety and financial toxicity in patients undergoing chemotherapy and their effect on treatment adherence

Chemotherapy-induced peripheral neuropathy with taxanes and platinum agents: incidence, risk factors and impact on quality of life

Clinico-pathological profile and treatment outcome of head and neck squamous cell carcinoma treated with induction chemotherapy

Metronomic chemotherapy in recurrent or metastatic head and neck cancer: response, toxicity and quality of life

Clinical profile and outcome of nasopharyngeal carcinoma treated with concurrent chemoradiation

Clinical profile and treatment outcome of metastatic castration-resistant prostate cancer with abiraterone or enzalutamide

Outcome of BEP chemotherapy in germ cell tumours and prognostic factors

Clinical profile and outcome of muscle-invasive bladder cancer treated with neoadjuvant chemotherapy

Clinico-pathological profile and treatment outcome of soft tissue sarcomas at a tertiary care centre

Outcome of osteosarcoma and Ewing sarcoma treated with multimodality therapy in adolescents and young adults

Clinical profile and outcome of gastrointestinal stromal tumours on imatinib

Clinical profile and outcome of cancer of unknown primary at a tertiary care centre

Oncological emergencies at presentation: spectrum, management and outcome in a medical oncology unit

Tumour lysis syndrome in haematological malignancies: incidence, risk factors and outcome with rasburicase

Venous thromboembolism in cancer patients: incidence, risk factors and adequacy of thromboprophylaxis using the Khorana score

Clinical profile and outcome of brain metastases from solid tumours and role of systemic therapy

Skeletal-related events in bone metastases and effect of zoledronic acid versus denosumab

Geriatric assessment and chemotherapy toxicity in elderly cancer patients using the CARG score

Treatment patterns and outcome of cancer in patients above 70 years at a tertiary oncology centre

Adherence to oral anticancer agents and factors affecting it in patients with chronic myeloid leukaemia and breast cancer

Ovarian function and fertility preservation practices in young women receiving chemotherapy

Hepatitis B reactivation in patients receiving rituximab-based chemotherapy and role of prophylactic antivirals

Response assessment with PET-CT versus contrast CT in lymphoma and solid tumours: concordance and impact on management

Clinical profile and outcome of triple-negative breast cancer and role of platinum-based neoadjuvant chemotherapy

Financial toxicity and out-of-pocket expenditure in cancer care at a public tertiary hospital

Clinical profile and outcome of oesophageal cancer treated with definitive chemoradiation versus surgery

Anaemia in cancer patients on chemotherapy: prevalence, etiology and response to intravenous iron and erythropoietin

All speciality × degree pages

MD topics

MS topics

DM (super-spec medical)

MCh (super-spec surgical)

DM Medical Oncology thesis — frequently asked questions